BioMar gains market share across all segments
The annual report for BioMar underlines the long-term positive development of the company. While volumes have increased, earnings were maintained at a robust level.
BioMar left 2025 with a total increase in feed volumes of 13%, reaching 1.56 million tonnes in 2025. The growth was primarily driven by a 31% increase in volumes in the Shrimp segment, while the Salmon segment grew by 8% and the Selected Species segment 11%. At the same time, volumes in the joint ventures in China and Türkiye increased by 21%.
“We have an unwavering focus on building up business with the right customers. We have not just gained market share but built up even stronger long-term partnerships with customers across the globe with whom we share a passion for building efficient and sustainable aquaculture. The volumes are primarily coming from customers who are taking lead in building new standards for the industry”, explains Carlos Diaz, CEO BioMar Group.
The company results were on par with 2024 in terms of EBIT, but with a further increase in return on invested capital, which rose from 21.2% in 2024 to 23.6% in 2025. For the first time, the results were significantly impacted by the Tech Solutions segment:
“We have during the last years invested in building up the Tech Solutions segment, enhanced our R&D capabilities, organisation and global sales presence. Looking back at 2025, it is rewarding to see how our strategic commitment to future-proofing the company by advancing feed solutions technology is gaining momentum and beginning to contribute to our earnings”, comments Carlos Diaz.
Complementing the business results, BioMar took several decisions during the year strengthening the organisation, acquiring full ownership of the business in Ecuador and in Costa Rica, while increasing research capacity for salmon in Norway by the purchase of the remaining shares in LetSea.
“In many ways, the year 2025 has been an important stepping stone in our development. We have been ramping up volumes, and in 2026 we expect to launch new lines in China and Ecuador, while investing in current production capabilities and new technology, preparing for even more organic growth. 2026 will be a transition year enabling us to reach our mid-term target of growing volumes organically 4-6% per year in average towards 2030”, continues Carlos Diaz and adds:
“Our owner, Schouw & Co., has decided to evaluate a separate listing of BioMar, which is ongoing. The process is extremely valuable for BioMar, enabling us to fortify our business even further. I am once again amazed by the dedication and hard work from all our employee contributing to this process as well as to the overall results of the business. Results are for sure created by people”.
Read more in BioMar's 2025 Annual Report.
Forward-looking statements
This press release contains forward-looking statements, which are based on current expectations, projections and assumptions about future events. Forward-looking statements are statements (other than statements of historical fact) relating to future events and BioMar’s anticipated or planned financial and operational performance. The words “may”, “will”, “should”, “expect”, “anticipate”, “believe”, “estimate”, “plan”, “predict”, “intend” or variations of these words, including negatives thereof, as well as other statements regarding matters that are not historical facts or regarding future events or prospects, constitute forward-looking statements. BioMar has based these forward-looking statements on its current views with respect to future events and financial performance. These views involve a number of known or unknown risks, uncertainties and assumptions, which could cause actual results to differ materially from those predicted in the forward-looking statements and from the past performance of BioMar. Although BioMar believes that the estimates and projections reflected in the forward-looking statements are reasonable, they may prove materially incorrect, and actual results may materially differ, e.g., as the result of risks related to the industry in general or BioMar in particular, including those described in BioMar’s Annual Report 2025 and other information made available by BioMar. As a result, you should not and may not rely on these forward-looking statements as a prediction of actual results. Forward-looking statements speak as of the date of this press release and no one undertakes to publicly update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by law.